Dicloxacillin

CAS: 3116-76-5

Ref. 3D-FD31341

Información del producto

• Nombre: Dicloxacillin
• Sinónimos: (2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, (2S,5R,6R)-6-[[[3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(2,6-Dichlorophenyl)-5-methyl-4-isooxazolylpenicillin, 3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolylpenicillin, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-, 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolecarboxamido]-3,3-dimethyl-7-oxo-, 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)-, 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, [2S-(2α,5α,6β)]-, 6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid, Brl 1702, Diclossacillina, Diclossacillina [DCIT], Dicloxacilin, Dicloxacilina, Dicloxacilina [INN-Spanish], Dicloxacillin [USAN:INN:BAN], Dicloxacilline, Dicloxacilline [INN-French], Dicloxacillinum, Dicloxacillinum [INN-Latin], Dicloxacycline, Hsdb 3222, Maclicine, Methyldichlorophenylisoxazolylpenicillin, R-13423, Stapenor D, Staphcillin A, Unii-Cof19H7Wbk, [3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolyl]penicillin, [5-Methyl-3-(2,6-dichlorophenyl)-4-isoxazolylyl]penicillin

Descripción

Dicloxacillin is a penicillin antibiotic that is used to treat infections caused by susceptible bacteria, such as Staphylococcus aureus and Streptococcus pneumoniae. Dicloxacillin has been shown to be effective against methicillin-resistant Staphylococcus aureus (MRSA) and Streptococcus pneumoniae. It binds to the penicillin-binding proteins in the bacterial cell wall by competitive inhibition. This binding prevents the formation of an antibiotic-inhibitor complex with the enzyme cell wall synthesis that is required for cell wall biosynthesis, inhibiting protein synthesis and cell division. Dicloxacillin also has antibacterial activity against Gram-positive cocci, including Enterococcus faecalis, Listeria monocytogenes, and Clostridium difficile.

• Marca: Biosynth

Propiedades químicas

• Pureza: Min. 95%